A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results. - Palma, D.A.; Kwan, K.; Gaede, S.; Landis, M.; Malthaner, R.; Fortin, D.; Louie, A.V.; Frechette, E.; Rodrigues, G.; Yaremko, B.; Yu, E.; Dar, A.R.; et al. (International Journal of Radiation Oncology, Biology, Physics, 2016)